Mutations of p53 in thyroid carcinoma with an insular component

被引:45
|
作者
Takeuchi, Y [1 ]
Daa, T
Kashima, K
Yokoyama, S
Nakayama, I
Noguchi, S
机构
[1] Oita Med Univ, Dept Pathol, Hasama, Oita 8795593, Japan
[2] Noguchi Thyroid Clin & Hosp Fdn, Beppu, Oita, Japan
关键词
D O I
10.1089/thy.1999.9.377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid carcinoma with an insular component (TCIC) is considered noteworthy in view of its peculiar histopathological features and clinicopathological behavior. The purpose of the present study was to clarify the rate of mutation in the p53 gene in TCIC as compared with rates in papillary and follicular carcinomas of the thyroid. Formalin-fixed and paraffin-embedded blocks of tissue from 46 cases of TCIC were analyzed. DNA was extracted from tissues and exons 5 through 8 of the p53 gene were amphfied by the polymerase chain reaction. Mutations were detected by analysis of single-strand conformation polymorphism. Of the 46 cases of TCIC, 6 had a mutation in exon 5, 2 in exon 7, and 5 in exon 8, while 1 case had mutations in all exons examined. The mutation rate of the p53 gene in TCIC was 38%. Immunostaining revealed overexpression of p53 in nuclei that were mainly in areas of the insular component rather than in surrounding areas of well-differentiated carcinoma. The frequency of positive immunostaining in TCIC was 53%. Considering that TCIC is intermediate between papillary plus follicular carcinoma and anaplastic carcinoma in terms of survival and the rate of mutation of the p53 gene, we can speculate that mutation in the p53 gene might be associated with the insular component and might play an important role in the clinicopathological behavior of thyroid carcinoma.
引用
收藏
页码:377 / 381
页数:5
相关论文
共 50 条
  • [31] Multiple p53 mutations are common in basal cell carcinoma
    Ponten, F
    Berg, C
    Uhlen, M
    Ponten, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 295 - 295
  • [32] Accurate detection of P53 mutations in transitional cell carcinoma
    White, RWD
    Shi, XB
    Gandour-Edwards, R
    Deitch, AD
    Figueroa, Y
    Yang, J
    JOURNAL OF UROLOGY, 2004, 171 (04): : 197 - 197
  • [33] P53 MUTATIONS IN ORAL SQUAMOUS-CELL CARCINOMA
    MAO, EJ
    DALING, J
    MAHAN, S
    BECKMANN, AM
    JOURNAL OF DENTAL RESEARCH, 1994, 73 : 263 - 263
  • [34] The incedece of p53 mutations in patients with oral squamocellular carcinoma
    Kozomara, R.
    Jovic, N.
    Stosic, S.
    Brankovic-Magic, M.
    Magic, Z.
    ORAL ONCOLOGY, 2007, : 191 - 191
  • [35] Multiple p53 mutations are common in basal cell carcinoma
    Ponten, F
    Berg, C
    Uhlen, M
    Ponten, J
    SKIN CANCER AND UV RADIATION, 1997, : 709 - 714
  • [36] P53 GENE-MUTATIONS IN HUMAN ENDOMETRIAL CARCINOMA
    RISINGER, JI
    DENT, GA
    IGNARTROWBRIDGE, D
    MCLACHLAN, JA
    TSAO, MS
    SENTERMAN, M
    BOYD, J
    MOLECULAR CARCINOGENESIS, 1992, 5 (04) : 250 - 253
  • [37] Anaplastic thyroid carcinoma: a screen for chromosomal and P53 alterations
    Rogue, L
    Martins, C
    Nunes, VM
    Marques, AR
    Leite, V
    Soares, J
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 130 - 130
  • [38] p53 gene mutations in radiation-induced thyroid cancer
    Fogelfeld, L
    Bauer, TK
    Schneider, AB
    Swartz, JE
    Zitman, R
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08): : 3039 - 3044
  • [39] p53 gene mutations in squamous cell carcinoma occurring in scars - Comparison with p53 protein immunoreactivity
    Sakatani, S
    Kusakabe, H
    Kiyokane, K
    Suzuki, K
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1998, 20 (05) : 463 - 467
  • [40] p53 mutations in cancer
    Muller, Patricia A. J.
    Vousden, Karen H.
    NATURE CELL BIOLOGY, 2013, 15 (01) : 2 - 8